| scholarly article | Q13442814 |
| P50 | author | Jana Fialova Kucerova | Q51017843 |
| Jan Václavík | Q57043921 | ||
| P2093 | author name string | Karel Indrak | |
| Jana Ulehlova | |||
| Ludek Slavik | |||
| Vera Krcova | |||
| P2860 | cites work | Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients | Q28195323 |
| Clopidogrel resistance? | Q28210522 | ||
| Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection | Q28218540 | ||
| Aspirin resistance: Where are we now? | Q38099524 | ||
| Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting | Q46045981 | ||
| Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary | Q46817738 | ||
| Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions | Q47991667 | ||
| Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). | Q50324461 | ||
| Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. | Q50695049 | ||
| Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate analyzer--comparison with two flow cytometric methods | Q80272594 | ||
| Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count | Q80292680 | ||
| The assessment of aspirin resistance by using light transmission and multiple electrode aggregometry | Q83159550 | ||
| Genetic polymorphisms of platelet glycoprotein Ia and the risk for premature myocardial infarction: effects on the release of sCD40L during the acute phase of premature myocardial infarction | Q83334039 | ||
| P433 | issue | 9 | |
| P921 | main subject | myocardial infarction | Q12152 |
| acute myocardial infarction | Q18558122 | ||
| P304 | page(s) | 599-604 | |
| P577 | publication date | 2014-08-05 | |
| P1433 | published in | Genetic Testing and Molecular Biomarkers | Q15753742 |
| P1476 | title | Genetic polymorphisms of platelet receptors in patients with acute myocardial infarction and resistance to antiplatelet therapy | |
| P478 | volume | 18 |
| Q90396100 | Aspirin & clopidogrel non-responsiveness & its association with genetic polymorphisms in patients with myocardial infarction |
| Q89260252 | Aspirin resistance in coronary heart disease: Current understandings and strategies |
| Q46342857 | Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention |
| Q92120444 | Effect of 106PEAR1 and 168PTGS1 genetic polymorphisms on recurrent ischemic stroke in Chinese patient |
| Q57045111 | Glycoprotein VI Gene Variants Affect Pregnancy Loss in Patients With Platelet Hyperaggregability |
| Q37602843 | Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivity |
| Q54979801 | Hypoxia and Ischemia Promote a Maladaptive Platelet Phenotype. |
| Q40049589 | NSAID resistance in dysmenorrhea: epidemiology, causes, and treatment. |
| Q38444433 | Pharmacogenomics of cyclooxygenases |
Search more.